Michael Ackermann - 15 Jun 2022 Form 4 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Role: Director
Signature: /s/ Leonard M. Greenstein, Attorney-in-Fact
Issuer symbol: TARS
Transactions as of: 15 Jun 2022
Transactions value $: $0
Form type: 4
Filing time: 17 Jun 2022, 16:51:24 UTC
Previous filing: 09 May 2022
Next filing: 01 Jul 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TARS	Common Stock	Options Exercise		+4.26K	+0.35%		1.21M	15 Jun 2022	Direct	F1
holding	TARS	Common Stock						100K	15 Jun 2022	By the Ackermann & Elmen-Gruys Trust Dated June 24, 2014	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TARS	Restricted Stock Units	Options Exercise	$0	-4.26K	-100%	$0.00^*	0	15 Jun 2022	Common Stock	4.26K		Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.
F2	The Reporting Person is the trustee of the Ackermann & Elmen-Gruys Trust Dated June 24, 2014 and has voting and dispositive power with respect to these shares.
F3	Each RSU represents a contingent right to receive one share of the Company's common stock.
F4	RSUs granted on June 15, 2021 in connection with the Reporting Person's service as a non-employee director as of the Company's 2021 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.